KMT2A siRNA (Mouse)

SiRNA to inhibit KMT2A expression using RNA interference

ALL1; HRX; MLL; MLL1; Histone-lysine N-methyltransferase 2A; Lysine N-methyltransferase 2A; ALL-1; Myeloid/lymphoid or mixed-lineage leukemia; Myeloid/lymphoid or mixed-lineage leukemia protein 1; Zinc finger protein HRX

M

Synthetic

RNAi

> 97%

Lyophilized powder

We offers pre-designed sets of 3 different target-specific siRNA oligo duplexes of mouse KMT2A gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot.

Shipped at 4 °C. Store at -20 °C for one year.

KMT2A siRNA (Mouse) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression.

KMT2A

Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.

P55200

214162